Using video feedback to strengthen interactions between parents with psychosis and their young children

ISRCTN ISRCTN34863912
DOI https://doi.org/10.1186/ISRCTN34863912
Integrated Research Application System (IRAS) 345724
Central Portfolio Management System (CPMS) 63188
National Institute for Health and Care Research (NIHR) 207967
Sponsor Oxford Health NHS Foundation Trust
Funder National Institute for Health and Care Research
Submission date
08/12/2025
Registration date
16/12/2025
Last edited
06/02/2026
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Psychosis is a severe mental health problem characterised by unusual sensory experiences and distressing beliefs, difficulties with motivation, and mood problems. Many patients with psychosis are parents, and their symptoms can impact on their ability to tune into their child’s communication and respond sensitively. This impacts on the parent’s and child’s wellbeing and increases the risk of future child mental health problems. There are no interventions supported by research to help this group of parents to interact with their children. We plan to evaluate an approach called video feedback. It involves the therapist and parent watching brief videotaped interactions between the parent and child, to help parents notice moments of positive interaction where they respond sensitively to their child’s communication. This approach helps parents to build on their strengths. While we know that video feedback works with other parent groups, we do not know whether it helps parents with psychosis. Before carrying out a trial to test video feedback with this patient group, this study will pilot the intervention and study procedures to determine if a larger trial is feasible.

Who can participate?
People aged 16-65 years with a diagnosed psychotic disorder, who are under the care of an NHS mental health team, and who have caregiving responsibilities for a child aged 2-36 months.

What does the study involve?
People taking part in the study will be divided into two groups. A computer will decide at random if participants are in group 1 (video feedback) or group 2 (treatment as usual), and there is a 50% chance of being put in either group.
Those in the video feedback group will receive eight 1-hour video feedback sessions with a trained therapist in their home or the clinic, spaced every 1-2 weeks. The therapist will video the parent and their child playing for a few minutes during some visits. In other visits, the parent will watch short clips from these videos that show positive moments of the parent and their child together, and parents will be asked about what is going well in the videos. Everyone taking part will continue to receive their usual mental health treatment and support in the team.
Everyone who takes part will be asked to meet with a research assistant at the beginning of the study, after 4 months and after 7 months. This research assistant does not know which group participants are in. During these research meetings, participants will be asked to complete questionnaires about their mental health, stress, wellbeing of their child, sources of support, and quality of life. The research assistant will also take a brief film clip of the parent and child playing together. At the end of the study some participants will be invited to take part in an interview with a member of the research team to talk about their experiences of the study.
The researchers will also interview the therapists about their experience of delivering video feedback, and survey other health practitioners in the recruiting teams to explore their views of the intervention and study.

What are the possible benefits and risks of participating?
It is not possible at this stage to say whether taking part will be of benefit to participants. We know from other research studies that parents have found video feedback helpful to build on their strengths and increase their parenting confidence. The information we get from this study will help us to improve the support offered to parents with psychosis in the future.
The risks of taking part are likely to be small. The research assessments involve parents talking about their mental health and their children, which they may find upsetting. Parents randomised to receive video feedback would need to put some time aside for these appointments. Some people can feel self-conscious watching clips of themselves and can worry whether others will judge them. The therapists are specially trained to help people deal with these feelings if they arise.

Where is the study run from?
Oxford Health NHS Foundation Trust and Leicestershire Partnership NHS Trust (UK)

When is the study starting and how long is it expected to run for?
January 2026 to March 2028

Who is funding the study?
National Institute for Health Research (NIHR) (UK)

Who is the main contact?
Dr Louise Johns, louise.johns@oxfordhealth.nhs.uk

Contact information

Dr Louise Johns
Scientific

Oxford Early Intervention Service
John Sharich House, Slade Site
Horspath Driftway
Oxford
OX3 7JH
United Kingdom

ORCiD logoORCID ID 0000-0003-3355-3202
Email louise.johns@oxfordhealth.nhs.uk

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingBlinded (masking used)
ControlActive
AssignmentSingle
PurposeTreatment
Scientific titleEnhancing the quality of interactions between parents with psychosis and their young children: a feasibility randomised controlled trial of video feedback
Study acronymEMBRACE
Study objectivesThe primary objective is to assess the feasibility and acceptability of conducting a randomised controlled trial of a brief video feedback intervention (Video Interaction Guidance [VIG]), versus usual care, in parents with a psychotic disorder who are a caregiver of a child aged 2-36 months.

The secondary objective is to collect data on pre-post changes on the following clinical outcomes:
1. Parent-child interaction
2. Parental mental health
3. Parenting stress
4. Child social and emotional wellbeing
for participants receiving VIG versus participants receiving usual care.
Ethics approval(s)Approved 17/10/2025, North of Scotland Research Ethics Committee 2 (North of Scotland Research Ethics Service, Summerfield House, 2 Eday Road, Aberdeen, AB15 6RE, UK; +44 (0)1224 558458; gram.nosres@nhs.scot), ref: 25/NS/0120
Health condition(s) or problem(s) studiedPsychosis
InterventionVideo Interaction Guidance (VIG):
VIG is a brief, strengths-based video feedback intervention that uses videotaped interactions of the parent and child to enhance parental responsiveness to the child’s cues. The VIG therapist films parent-child interactions for 5 minutes and then edits the footage to produce three short video clips (up to 30 seconds) of successful interaction that link to the parent’s goals. In the subsequent ‘shared review’ session, the parent and VIG therapist review the selected clips together. Seeing the videos with the therapist allows the parent to build on moments of positive interaction with their child. One cycle of VIG involves filming (session 1), editing (between sessions), and reviewing video clips (session 2). Parents will receive an introductory session, 3 cycles of VIG (one cycle = two sessions, over 2-3 weeks), and a review session. The intervention will be delivered over 8-10 weeks. Sessions last 45-60 minutes and are delivered in the parent’s home or the clinic.

Usual Care:
All participants will continue to receive usual care from their treating team. Usual care includes care-coordination, psychiatric review, medication, psychological therapy, family therapy and carer support (for the patient’s caregivers), physical health monitoring, peer support, and, in perinatal teams, parenting skills support. We will not ask referrers or clinicians to withhold any treatment offered as part of usual care in either trial arm.
Intervention typeBehavioural
Primary outcome measure(s)

The primary outcome measures relate to the feasibility and acceptability of the trial procedures and intervention.

The primary efficacy outcome is parent-child interaction (parental responsiveness), assessed using video clips coded using the Emotional Availability (EA) Scales by trained independent raters, at baseline, 16 weeks, and 28 weeks. The video clips of parents and infants up to 15 months will also be rated on the CARE-index by a trained independent rater at baseline, 16 weeks and 28 weeks.

Feasibility parameters measured at baseline, 16 and 28 weeks:
1. Number of patients eligible, approached, and consented to participate
2. Number recruited, recruitment rate, and proportion of mothers and fathers recruited
3. Range and average number of sessions attended
4. Proportion of participants completing all planned intervention sessions
5. Number of participants who withdraw from the study and when they withdraw
6. Any adverse effects of participating in the study
7. Acceptability of the intervention, assessed qualitatively post-intervention
8. Reasons for participants not completing the intervention as planned, assessed qualitatively post-intervention
9. Number of participants who complete the outcome measures at each time point and the completeness of their data, and acceptability of the measures assessed qualitatively post-intervention

Key secondary outcome measure(s)

1. Parent-child interaction is assessed using video clips coded on the Emotional Availability (EA) Scales by trained independent raters at baseline, 16 weeks, and 28 weeks. Video clips of parents and infants up to 15 months are also coded by independent raters on the CARE-index at baseline, 16 weeks, and 28 weeks.
2. Parental mental health is measured using the Depression, Anxiety and Stress Scale at baseline, 16 and 28 weeks
3. Parenting stress is measured using the Parental Stress Scale at baseline, 16 and 28 weeks
4. Social and emotional wellbeing of children is assessed using the parent-reported Ages and Stages Questionnaire: Social and Emotional at baseline, 16 and 28 weeks
5. Health and social care use by the parent and child is assessed using the Client Service Receipt Inventory (CSRI), adapted for this patient group, at baseline and 28 weeks
6. Parental quality of life is measured using the EQ-5D-5L at baseline, 16 and 28 weeks
7. NHS treatments and service use are extracted from the electronic patient record at baseline and 28 weeks

Completion date31/12/2027

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration40
Key inclusion criteriaParent:
1. Patient of mental health services (at the time of referral to the trial)
2. A clinical diagnosis of schizophrenia spectrum psychosis (non-affective psychosis) (ICD 10 codes F20–29) or bipolar disorder (F31) with psychotic symptoms (affective psychosis)
3. Caregiving responsibilities for child aged 2-36 months
4. Able to speak English or, if not, willing to involve an interpreter to engage in the trial
5. Willing and able to give informed consent

Child:
1. Aged between 2 and 36 months at the time of the parent's referral to the trial
2. In regular contact with the participating parent
3. The child’s parent or legal guardian has provided informed consent for their participation in the study procedures

Parent qualitative study:
1. Consent to have interviews audio recorded
2. Participation in the study (n = 5); randomised to the intervention arm and having received at least one cycle of VIG (n = 10)

Clinician qualitative study:
1. Consent to have interviews audio recorded
2. Experience of either delivering VIG to study participants, or referring a parent to the study, or working with parents with psychosis and young children in the recruiting Trusts.
Key exclusion criteriaParent:
1. A co-parent is participating in the trial
2. The parent is engaged in another parenting intervention
3. The eligible parent has psychotic symptoms or cognitive difficulties or substance misuse problems that are sufficiently severe to prevent them engaging with the intervention or completing study measures
4. Contact between the parent and child is not permitted by social services
5. Any other factor (for example, current active suicidal plans) which, in the judgement of the investigator, would preclude the participant from providing informed consent or from safely engaging with the trial procedures.

Child:
1. Contact with the participating parent is prohibited by social services or a court order
2. The child is already enrolled in another parenting study
3. A sibling is participating in the trial
Date of first enrolment05/01/2026
Date of final enrolment01/08/2027

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centres

Slade Site
Horspath Driftway
Headington
Oxford
OX3 7JH
England
Warneford Hospital
Warneford Lane
Headington
Oxford
OX3 7JX
England
Whiteleaf Centre
Bierton Road
Aylesbury
HP20 1EG
England
Leicestershire Partnership NHS Trust Mental Health Services
George Hine House
Gipsy Lane
Humberstone
Leicester
LE5 0TD
England
Merlyn Vaz Health and Social Care Centre
1 Spinney Hill Road
Leicester
LE5 3GH
England

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon reasonable request from Dr Louise Johns (louise.johns@oxfordhealth.nhs.uk). De-identified data will be made available to external researchers subject to the constraints of the consent under which data were collected, with an appropriate data sharing agreement, and after publication of the main study report.

Editorial Notes

06/02/2026: Individual participant data (IPD) sharing plan added.
08/12/2025: Study's existence confirmed by the NIHR.